The Practitioner 2010 – 254 (1730): 8-10

Does active surveillance for prostate cancer cause anxiety?

22 Jun 2010

AUTHORS

Dr Jonathan Rees
GPwSI Urology, Bristol

Article

Anxiety and distress levels do not change significantly during active surveillance for low-risk prostate cancer, the findings of a small Dutch study suggest.

A total of 150 men with low-risk prostate cancer, within a larger prospective active surveillance study, were questioned. Patients were asked to complete a questionnaire at study inclusion and at 9 months after diagnosis. Scores for: decisional conflict; depression; anxiety (both general and prostate cancer specific): and self-estimated risk of progression were recorded.

In all, 129 men completed the questionnaire at the start of the study and 108 at 9 months following diagnosis. In the meantime, nine men switched from active surveillance to active treatment, two of them for reasons not indicated by the protocol. The latter two patients cited a lack of confidence in active surveillance and the contradictory opinions of two doctors as the main reasons for discontinuation.

Anxiety and depression scores were generally low at study inclusion, and remained so throughout the study.

A small but not clinically significant improvement in scores for general and prostate-specific anxiety (fear of progression) and self-estimated risk of progression was seen.

Higher scores for anxiety and distress at the start of the study were the best predictors for high scores at

9 months after diagnosis.

However, a neurotic personality type and the perception that the physician played an important role in making the decision to opt for active surveillance also predicted higher decisional conflict scores.

Men with low neurotic personality scores and those with the best physical health were seen to perform best from a psychological point of view during the study.

These results are useful to clinicians involved in helping patients in this complex decision making process.

The impact of perceived physician involvement in decision making is important and emphasises the need for greater patient involvement.

As well as informative literature and interactive technology, prostate cancer specialist nurses can also play a key role. These nurses have been shown to have a hugely beneficial role in helping patients arrive at a management decision.

 

Dr Jonathan Rees

 

REFERENCES

• van den Bergh RCN, Essink-Bot M-L, Roobol MJ et al. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol 2010;183:1786-1791